Wen Hannah Y, Brogi Edi
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8.
Lobular carcinoma in situ (LCIS) is a risk factor and a nonobligate precursor of breast carcinoma. The relative risk of invasive carcinoma after classic LCIS diagnosis is approximately 9 to 10 times that of the general population. Classic LCIS diagnosed on core biopsy with concordant imaging and pathologic findings does not mandate surgical excision, and margin status is not reported. The identification of variant LCIS in a needle core biopsy specimen mandates surgical excision, regardless of radiologic-pathologic concordance. The presence of variant LCIS close to the surgical margin of a resection specimen is reported, and reexcision should be considered.
小叶原位癌(LCIS)是乳腺癌的一个风险因素和非必然前期病变。经典LCIS诊断后发生浸润性癌的相对风险约为普通人群的9至10倍。经粗针穿刺活检诊断的经典LCIS,若影像学和病理结果一致,则无需手术切除,也无需报告切缘情况。在针芯活检标本中识别出变异型LCIS则需要手术切除,无论放射学与病理学是否一致。若切除标本的手术切缘附近存在变异型LCIS,则需报告,且应考虑再次切除。